Form 4: Hologic exec withholds 178 shares for RSU taxes

Hologic’s GYN Surgical President Brandon Schnittker withheld 178 shares at $74.15 to cover taxes on RSU vesting, leaving 17,602 shares owned directly.

Summary

• Brandon Schnittker, President of GYN Surgical at Hologic (HOLX), reported a Form 4 insider transaction.
• On 2025-11-14, 178 common shares were withheld (Code F) to satisfy tax obligations tied to RSU settlement after service-based vesting.
• Implied price per share for the withholding was $74.15.
• Post-transaction, Schnittker directly owns 17,602 Hologic shares.
• No open-market purchase or sale occurred; this was a net share settlement for taxes.
• Form signed by attorney-in-fact on 2025-11-18.

Sentiment

Score: 5

Explanation: Routine insider tax withholding on RSU vesting; neutral for fundamentals and price outlook.

Positives

• No open-market sale: shares were withheld solely to satisfy tax obligations on RSUs (Code F).
• Insider retains a notable stake post-transaction: 17,602 shares directly owned.
• Service-based vesting satisfied, indicating continued tenure through vesting dates.

Negatives

• Direct holdings decreased by 178 shares due to tax withholding.
• No operational, financial, or strategic information provided to assess fundamentals.

Future Outlook

No forward-looking statements or guidance provided.

Management Comments

• Shares were withheld to cover tax obligations in connection with the settlement of RSUs for which service-based vesting requirements were satisfied.

Industry Context

Net share settlement to cover taxes on RSU vesting is standard practice across medtech and broader corporate America and does not, by itself, indicate a bullish or bearish view by the insider.

Comparison to Industry Standards

• Consistent with peers such as Boston Scientific (BSX), Stryker (SYK), and Intuitive Surgical (ISRG), where executives commonly use net share settlement (Code F) for RSU tax obligations.
• Transaction size (low hundreds of shares) aligns with routine vesting events and is immaterial relative to market capitalization and daily trading volumes among large-cap medtech companies.
• No deviation from typical Section 16 reporting norms: timely disclosure, clear code usage, and post-transaction beneficial ownership stated.

Stakeholder Impact

• Administrative in nature; no operational or financial changes disclosed.
• Insider continues to hold 17,602 shares, indicating ongoing equity alignment.

Key Dates

Keywords

Hologic, HOLX, Form 4, insider transaction, restricted stock units, RSU vesting, tax withholding, beneficial ownership, Brandon Schnittker, GYN Surgical, Section 16